Cargando…
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
Autores principales: | Ponzo, Matteo, Debesset, Anais, Cossutta, Mélissande, Chalabi-Dchar, Mounira, Houppe, Claire, Pilon, Caroline, Nicolas-Boluda, Alba, Meunier, Sylvain, Raineri, Fabio, Thiolat, Allan, Nicolle, Rémy, Maione, Federica, Brundu, Serena, Cojocaru, Carina Florina, Bouvet, Philippe, Bousquet, Corinne, Gazeau, Florence, Tournigand, Christophe, Courty, José, Giraudo, Enrico, Cohen, José L., Cascone, Ilaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776549/ https://www.ncbi.nlm.nih.gov/pubmed/36551754 http://dx.doi.org/10.3390/cancers14246160 |
Ejemplares similares
-
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression
por: Ponzo, Matteo, et al.
Publicado: (2022) -
Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma
por: Raineri, Fabio, et al.
Publicado: (2021) -
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation
por: Chalabi-Dchar, Mounira, et al.
Publicado: (2021) -
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy
por: Diamantopoulou, Zoi, et al.
Publicado: (2017) -
Integrated analysis of mRNA and miRNA expression in HeLa cells expressing low levels of Nucleolin
por: Kumar, Sanjeev, et al.
Publicado: (2017)